Professor | Li Wang | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Li Wang
Contact Information	wangli@hrbmu.edu.cn
Language ability	Chinese, English
Province	Heilongjiang

Upload Avatar (500 x 500)

Name

Li Wang

Contact Information

wangli@hrbmu.edu.cn

Language ability

Chinese, English

Province

Heilongjiang

University/Lab Affiliation and Title	Harbin Medical University
Faculty	College of Bioinformatics Science and Technology
Awards	Heilongjiang Province High-level Talent Heilongjiang Province Excellent Youth Heilongjiang Province Innovative Talent University-level Outstanding Scientific Research Worker Top Ten Youth Post Expert Excellent Teacher May Fourth Youth Medal

University/Lab Affiliation and Title

Harbin Medical University

Faculty

College of Bioinformatics Science and Technology

Awards

Heilongjiang Province High-level Talent
Heilongjiang Province Excellent Youth
Heilongjiang Province Innovative Talent
University-level Outstanding Scientific Research Worker
Top Ten Youth Post Expert
Excellent Teacher
May Fourth Youth Medal

Areas of Focus	Malignant tumor heterogeneity analysis Early diagnosis Cancer treatment decision-making Prognosis evaluation Biomedical big data Artificial intelligence Single-cell and spatial transcriptomics Cancer evolution molecular mechanisms Tumor immune microenvironment Immunotherapy
Publications	LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA-target regulations in human diseases., Li Wang, 2023 Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes., Li Wang, 2021 LncTarD: a manually-curated database of experimentally-supported functional lncRNA-target regulations in human diseases., Li Wang, 2020 The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis., Li Wang, 2022 Lnc2Cancer v2.0: updated database of experimentally supported long non-coding RNAs in human cancers., Li Wang, 2019 Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines., Li Wang, 2020 Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer., Li Wang, 2023 Integrated analysis of single-cell and bulk RNA sequencing data reveals immune-related lncRNA-mRNA prognostic signature in triple-negative breast cancer., Li Wang, 2023 Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data., Li Wang, 2022 Comprehensive identification and potential application of genetic alteration-driven enhancer RNAs for eRNA-targeted therapy in breast cancer., Li Wang, 2023 Genome-wide DNA methylome analysis reveals a critical role of methylation-dysregulated lncRNAs in autophagy regulation in glioblastoma., Li Wang, 2023 Identification of somatic mutation-driven enhancers and their clinical utility in breast cancer., Li Wang, 2024

Areas of Focus

Malignant tumor heterogeneity analysis
Early diagnosis
Cancer treatment decision-making
Prognosis evaluation
Biomedical big data
Artificial intelligence
Single-cell and spatial transcriptomics
Cancer evolution molecular mechanisms
Tumor immune microenvironment
Immunotherapy

Publications

LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA-target regulations in human diseases., Li Wang, 2023
Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes., Li Wang, 2021
LncTarD: a manually-curated database of experimentally-supported functional lncRNA-target regulations in human diseases., Li Wang, 2020
The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis., Li Wang, 2022
Lnc2Cancer v2.0: updated database of experimentally supported long non-coding RNAs in human cancers., Li Wang, 2019
Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines., Li Wang, 2020
Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer., Li Wang, 2023
Integrated analysis of single-cell and bulk RNA sequencing data reveals immune-related lncRNA-mRNA prognostic signature in triple-negative breast cancer., Li Wang, 2023
Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data., Li Wang, 2022
Comprehensive identification and potential application of genetic alteration-driven enhancer RNAs for eRNA-targeted therapy in breast cancer., Li Wang, 2023
Genome-wide DNA methylome analysis reveals a critical role of methylation-dysregulated lncRNAs in autophagy regulation in glioblastoma., Li Wang, 2023
Identification of somatic mutation-driven enhancers and their clinical utility in breast cancer., Li Wang, 2024

Tumor Heterogeneity Early Diagnosis Cancer Treatment Prognosis Big Data Ai Transcriptomics Molecular Mechanisms Immune Microenvironment Immunotherapy

Hongying Zhao - Harbin Medical University

Jinyuan Xu - Harbin Medical University

Yihan Wang - Harbin Medical University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us